CN106259071A - A kind of natural cultural method of crab - Google Patents
A kind of natural cultural method of crab Download PDFInfo
- Publication number
- CN106259071A CN106259071A CN201610642486.8A CN201610642486A CN106259071A CN 106259071 A CN106259071 A CN 106259071A CN 201610642486 A CN201610642486 A CN 201610642486A CN 106259071 A CN106259071 A CN 106259071A
- Authority
- CN
- China
- Prior art keywords
- crab
- water
- pond
- parts
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 228
- 239000003814 drug Substances 0.000 claims abstract description 57
- 230000000694 effects Effects 0.000 claims abstract description 41
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 239000011812 mixed powder Substances 0.000 claims abstract description 25
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 23
- 241000238557 Decapoda Species 0.000 claims description 62
- 235000011399 aloe vera Nutrition 0.000 claims description 42
- 241001116389 Aloe Species 0.000 claims description 37
- 239000000654 additive Substances 0.000 claims description 27
- 230000000996 additive effect Effects 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 26
- 241000272201 Columbiformes Species 0.000 claims description 24
- 210000003608 fece Anatomy 0.000 claims description 20
- 239000010871 livestock manure Substances 0.000 claims description 17
- 235000013372 meat Nutrition 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 240000001972 Gardenia jasminoides Species 0.000 claims description 15
- 230000003203 everyday effect Effects 0.000 claims description 15
- 241000185686 Apocynum venetum Species 0.000 claims description 14
- 210000000988 bone and bone Anatomy 0.000 claims description 14
- 238000012364 cultivation method Methods 0.000 claims description 14
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 11
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 11
- 244000082204 Phyllostachys viridis Species 0.000 claims description 11
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 11
- 239000011425 bamboo Substances 0.000 claims description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 10
- 239000003415 peat Substances 0.000 claims description 10
- 239000002985 plastic film Substances 0.000 claims description 10
- 229920006255 plastic film Polymers 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 239000002689 soil Substances 0.000 claims description 10
- 244000194101 Ginkgo biloba Species 0.000 claims description 9
- 244000294611 Punica granatum Species 0.000 claims description 9
- 235000014360 Punica granatum Nutrition 0.000 claims description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 9
- 240000002234 Allium sativum Species 0.000 claims description 8
- 235000011201 Ginkgo Nutrition 0.000 claims description 8
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 8
- 235000004611 garlic Nutrition 0.000 claims description 8
- 241000213006 Angelica dahurica Species 0.000 claims description 7
- 244000025254 Cannabis sativa Species 0.000 claims description 7
- 235000008113 selfheal Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 6
- 240000003146 Lobelia chinensis Species 0.000 claims description 6
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 6
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 6
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 6
- 238000005266 casting Methods 0.000 claims description 6
- 235000013601 eggs Nutrition 0.000 claims description 6
- 239000012286 potassium permanganate Substances 0.000 claims description 6
- 244000026873 Alternanthera philoxeroides Species 0.000 claims description 5
- 241000195628 Chlorophyta Species 0.000 claims description 5
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 5
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 5
- 240000003826 Eichhornia crassipes Species 0.000 claims description 5
- 235000019733 Fish meal Nutrition 0.000 claims description 5
- 241000287828 Gallus gallus Species 0.000 claims description 5
- 241000237858 Gastropoda Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 244000052355 Hydrilla verticillata Species 0.000 claims description 5
- 244000017020 Ipomoea batatas Species 0.000 claims description 5
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 5
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 5
- 241000543445 Vallisneria spiralis Species 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- 210000003278 egg shell Anatomy 0.000 claims description 5
- 239000004467 fishmeal Substances 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 235000011477 liquorice Nutrition 0.000 claims description 5
- 230000035699 permeability Effects 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 claims description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 4
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 4
- 241000219784 Sophora Species 0.000 claims description 4
- 241000316342 Taxillus Species 0.000 claims description 4
- 241000488974 Loranthus Species 0.000 claims description 3
- 238000012136 culture method Methods 0.000 claims description 3
- 241000202726 Bupleurum Species 0.000 claims description 2
- 240000007890 Leonurus cardiaca Species 0.000 claims description 2
- 240000001949 Taraxacum officinale Species 0.000 claims description 2
- 230000003071 parasitic effect Effects 0.000 claims description 2
- 244000179560 Prunella vulgaris Species 0.000 claims 2
- 230000001954 sterilising effect Effects 0.000 abstract description 8
- 230000004083 survival effect Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 241001106462 Ulmus Species 0.000 abstract description 2
- 230000008859 change Effects 0.000 abstract description 2
- 230000000366 juvenile effect Effects 0.000 abstract 2
- 241000371997 Eriocheir sinensis Species 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 20
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 16
- 210000002216 heart Anatomy 0.000 description 16
- 230000001965 increasing effect Effects 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- 210000002700 urine Anatomy 0.000 description 13
- 241000722949 Apocynum Species 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000002147 killing effect Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- 239000000292 calcium oxide Substances 0.000 description 8
- 235000012255 calcium oxide Nutrition 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000000747 cardiac effect Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 6
- 230000010415 tropism Effects 0.000 description 6
- 244000144927 Aloe barbadensis Species 0.000 description 5
- 235000002961 Aloe barbadensis Nutrition 0.000 description 5
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 240000002800 Sanicula europaea Species 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 229930182486 flavonoid glycoside Natural products 0.000 description 4
- 150000007955 flavonoid glycosides Chemical class 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000000749 insecticidal effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 238000010253 intravenous injection Methods 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- KMEHEQFDWWYZIO-UHFFFAOYSA-N triacontyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC KMEHEQFDWWYZIO-UHFFFAOYSA-N 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- FHIREUBIEIPPMC-UHFFFAOYSA-N K-Strophanthin-beta Natural products O1C(C)C(OC2C(C(O)C(O)C(CO)O2)O)C(OC)CC1OC(CC1(O)CCC2C3(O)CC4)CCC1(C=O)C2CCC3(C)C4C1=CC(=O)OC1 FHIREUBIEIPPMC-UHFFFAOYSA-N 0.000 description 3
- 241000207925 Leonurus Species 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 241000245665 Taraxacum Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000003359 percent control normalization Methods 0.000 description 3
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- CTNPHHZPAJYPFO-PDXBGNJTSA-N (3s,5s,8r,9s,10s,13r,14s,17r)-3-[(2r,4s,5r,6r)-5-[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,14-dihydroxy-13-methyl-17-(5-oxo-2h-furan Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C=O)CC[C@@H](C[C@@]5(O)CC[C@H]4[C@@]3(O)CC2)O[C@H]2C[C@@H]([C@@H]([C@@H](C)O2)O[C@@H]2[C@H]([C@H](O)[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](CO)O2)O)OC)=CC(=O)OC1 CTNPHHZPAJYPFO-PDXBGNJTSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 241000242722 Cestoda Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229920002558 Curdlan Polymers 0.000 description 2
- 239000001879 Curdlan Substances 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 244000111489 Gardenia augusta Species 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- BWXDHBQGBNPJMN-VBHWJLTNSA-N [(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] hexadecanoate Chemical compound C([C@@]1(C)CC[C@H]([C@@H]1[C@H]1CC[C@H]23)C(C)=C)C[C@@]1(C)[C@]3(C)CC[C@@H]1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC)C1(C)C BWXDHBQGBNPJMN-VBHWJLTNSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- -1 aloe-emodin glycoside Chemical class 0.000 description 2
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 2
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 229930182482 anthraquinone glycoside Natural products 0.000 description 2
- 229940098421 anthraquinone glycoside Drugs 0.000 description 2
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019316 curdlan Nutrition 0.000 description 2
- 229940078035 curdlan Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- ROOBHHSRWJOKSH-UHFFFAOYSA-N hentriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO ROOBHHSRWJOKSH-UHFFFAOYSA-N 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 2
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 2
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 201000003152 motion sickness Diseases 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N palmityl palmitate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 2
- 229960002646 scopolamine Drugs 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 241000879217 Apocynum androsaemifolium Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010065929 Cardiovascular insufficiency Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- XQCGNURMLWFQJR-ZNDDOCHDSA-N Cymarin Chemical compound O1[C@H](C)[C@@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)CC[C@@H]3[C@@]2(C=O)CC1 XQCGNURMLWFQJR-ZNDDOCHDSA-N 0.000 description 1
- XQCGNURMLWFQJR-UESCRGIISA-N Cymarin Natural products O=C[C@@]12[C@@](O)(C[C@@H](O[C@H]3O[C@@H](C)[C@@H](O)[C@@H](OC)C3)CC1)CC[C@H]1[C@]3(O)[C@@](C)([C@H](C4=CC(=O)OC4)CC3)CC[C@H]21 XQCGNURMLWFQJR-UESCRGIISA-N 0.000 description 1
- 206010063057 Cystitis noninfective Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000733943 Hapalogaster mertensii Species 0.000 description 1
- 208000025599 Heat Stress disease Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- BWXDHBQGBNPJMN-UHFFFAOYSA-N Lupeol palmitate Natural products C12CCC3C4C(C(C)=C)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(OC(=O)CCCCCCCCCCCCCCC)C1(C)C BWXDHBQGBNPJMN-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- HJBUYKZTEBZNSH-ONJCETCRSA-N Neoliquiritin Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C(=O)C[C@@H](O2)C=3C=CC(O)=CC=3)C2=C1 HJBUYKZTEBZNSH-ONJCETCRSA-N 0.000 description 1
- HJBUYKZTEBZNSH-ZRWXNEIDSA-N Neoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C(=O)C[C@H](O2)C=3C=CC(O)=CC=3)C2=C1 HJBUYKZTEBZNSH-ZRWXNEIDSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000517304 Pthirus pubis Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010066371 Tendon pain Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 231100000457 cardiotoxic Toxicity 0.000 description 1
- 230000005928 cardiotoxic reaction Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 201000003139 chronic cystitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 229960003083 cymarin Drugs 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- FHIREUBIEIPPMC-SADZTDHOSA-N k-Strophanthin-beta Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C=O)CC[C@@H](C[C@@]5(O)CC[C@H]4[C@@]3(O)CC2)O[C@H]2C[C@@H]([C@@H]([C@@H](C)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)OC)=CC(=O)OC1 FHIREUBIEIPPMC-SADZTDHOSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003895 organic fertilizer Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- YWORCEHQVMOKDM-UHFFFAOYSA-H tricalcium;1-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O.[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O YWORCEHQVMOKDM-UHFFFAOYSA-H 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides the natural cultural method of a kind of crab, comprises the following steps: 1) pond foundation;2) juvenile crab selects;3) water treatment: nursery pond, before putting juvenile crab 12~15 days, the Chinese medicine mixed powder I of every mu of use 90~110 kilograms splashed sterilization;Culturing pool: every 10~15 days, take Chinese medicine mixed powder II: Bulbus Allii 1~2 parts, Fructus Gardeniae 1~2 parts, Fructus Ulmus preparatium 0.1~0.3 part, Folium Pleioblasti 0.2~0.4 part, Folium Apocyni Veneti 0.1~0.3 part that following raw material pulverizing obtains, spill according to every mu and put the Chinese medicine mixed powder II of 120~140 kilograms and carry out disinfection;4) Seedling is put;5) add water change water process;6) bait throwing in management.Water treatment of the present invention uses Chinese medicine to carry out disinfection, and has sterilization and nutrition concurrently, has pure natural, noresidue, toxic and side effects advantage little, free of contamination, improve survival rate and the quality of Eriocheir sinensis.
Description
[ technical field ] A method for producing a semiconductor device
The invention relates to a culture method, in particular to a natural culture method of river crabs.
[ background of the invention ]
The crab meat contains multiple vitamins, wherein vitamin A is higher than that of other terrestrial and aquatic animals, and vitamin B2 is 5-6 times of meat, 6-10 times higher than that of fish, and 2-3 times higher than that of eggs. The content of vitamin B1 and phosphorus is 6-10 times higher than that of common fish. Every 100 g of hairy crab edible part contains 17.5 mg of protein, 2.8 g of fat, 182 mg of phosphorus, 126 mg of calcium and 2.8 mg of iron. The crab shell contains rich calcium, crab red pigment, crab flavin and the like, so that the river crab is cultured in a large amount.
At present, the conventional method for breeding river crabs comprises the following steps: 1) selecting crab seedlings; 2) treating the water quality of the pond; directly splashing quicklime for sterilization; 3) putting seedlings; 4) bait casting management; the crabs in any stage are treated by the quicklime, and because the bodies of the crabs in different stages are different, the required growth environments are different, and the crabs are blindly disinfected by the quicklime, the survival rate of the crabs is low, and the quality of the crabs is reduced.
[ summary of the invention ]
In view of the above problems, the present invention provides a natural cultivation method of river crabs, which treats the water quality of the crabs cultured in different stages in different ways, is suitable for the growth environment of the crabs, and improves the survival rate and quality.
In order to achieve the purpose, the invention adopts the following technical scheme: a natural cultivation method of river crabs comprises the following steps:
1) establishing a pond: is divided into a seedling raising pond and a culture pond; wherein,
a seedling raising pond: selecting a place with sufficient water source, convenient water inlet and drainage, good water quality, no pollution and good air permeability, wherein the area is 0.5-1 mu, the gradient ratio is 0.5: 1-2, a crab ditch with the depth of 0.3-0.4 m and the width of 1-2 m is dug in the pool, anti-escape walls with the height of 50-60 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the pool is 30-40 cm, and the water level of a deep water area is 60-70 cm; the water inlet and the water outlet are both provided with round holes with the diameter of 10-15 cm, and are both provided with a filter screen with the mesh of 50-70; the method comprises the following steps of planting tape grass, alternanthera philoxeroides and red eggs in a pond according to the water plant coverage rate of 50-60%, throwing small stones with the total height of 5-10 cm and the diameter of 2-8 cm, and putting 5-8 kg of peat soil in each mu;
a culture pond: the area of the crab ditch is 2-3 mu, the slope is 1: 2-2.5, crab ditches with the depth of 1-1.5 m and the width of 4-5 m are dug in the crab ditch, escape-preventing walls with the height of 60-70 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the culture pond is 60-70 cm, and the water level of a deep water area is 100-120 cm; the water inlet and the water outlet are both provided with circular holes with the diameter of 12-17 cm and are both provided with 80-100 mesh filter screens; the method is characterized in that hydrilla verticillata, water hyacinth, chlorophyta and green chrysanthemum are used as main materials in the pond, the grass consumption per mu is 13-16kg, the row spacing is 0.8-1m, stones with the total height of 8-12 cm and the diameter of 5-9 cm are thrown in the pond, and in addition, 10-20 kg of peat soil is thrown in each mu;
2) crab larva selection: crab seedlings with the weight of 50-80 g, consistent specification, consistent body color and strong activity;
3) water quality treatment:
and (3) sprinkling 90-110 kg of traditional Chinese medicine mixed powder I for disinfection per mu 12-15 days before crab larvae are put in the nursery pond, and keeping the water temperature at 18-25 ℃, wherein the traditional Chinese medicine mixed powder I is formed by crushing the following raw materials in parts by weight: 1-2 parts of aloe powder, 2-3 parts of ginkgo, 0.2-0.4 part of pigeon manure, 1-2 parts of gardenia and 0.1-0.3 part of pomegranate bark;
a culture pond: every 10-15 days, taking the following raw materials to obtain traditional Chinese medicine mixed powder II: 1-2 parts of garlic, 1-2 parts of gardenia, 0.1-0.3 part of fructus ulmi, 0.2-0.4 part of bitter bamboo leaf and 0.1-0.3 part of apocynum venetum leaf; then, spraying 120-140 kilograms of traditional Chinese medicine mixed powder II per mu for disinfection, and keeping the water temperature at 20-25 ℃;
4) seedling releasing: before seedling release, potassium permanganate is used for 10-15 g/m3Soaking the solution for 2-3 minutes, then putting the solution into clear water for 8-10 minutes, repeating the soaking for 2-3 times, then putting the disinfected crab seedlings into a seedling pool for 10-20 crab seedlings per time, and after all the crab seedlings are slowly scattered, then putting the rest crab seedlings into the seedling pool in the manner;
5) adding water and changing water treatment: the seedling raising pond is changed every 10 days to keep the water quality transparency of the shallow water area above 20cm and the water quality transparency of the deep water area above 50 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 35cm and the average water level of the deep water area at 65 cm;
a culture pond: changing water every 5-8 days to keep the water quality transparency of the shallow water area above 50cm and the water quality transparency of the deep water area above 80 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 65cm and the average water level of the deep water area at 110 cm;
6) bait casting management:
a) the first stage is as follows: feeding twice with bait I1-10 days after the crab larvae are placed in a nursery pond, wherein each bait I is 0.01-0.02 time of the weight of the crab larvae, and comprises the following components: soybean starch, dried snail meat, sweet potato powder and a Chinese herbal medicine additive I, wherein the Chinese herbal medicine additive I is prepared from the following raw materials: licorice, selfheal, radix sophorae flavescentis, parasitic loranthus, Chinese date, Chinese angelica and Chinese lobelia;
b) and a second stage: feeding the crabs for 11-20 days after the crabs are placed in a nursery pond for three times every day by adopting bait II, wherein each bait II is 0.07-0.09 time of the weight of the crabs, and comprises the following components: corn starch, screw meat, fish meal and a traditional Chinese medicine additive II, wherein the traditional Chinese medicine additive II is prepared from the following raw materials: the Chinese medicinal additive II is added into a grinder to be ground and then pass through a sieve of 10-30 meshes;
c) and a third stage: feeding the crabs for three times every day by adopting bait II within 5 months after the crabs are transferred from the nursery pond to the culture pond, wherein each crab is fed according to 0.1-0.3 time of the weight of the crab;
d) a fourth stage: after 5 months of transferring the crabs from the nursery pond to the culture pond, feeding the crabs for three times every day by using bait III, wherein each bait III is 0.5 time of the weight of the crab, and comprises the following components: chicken, egg shell powder, meat and bone powder, vitamins and bone powder.
The invention has the following beneficial effects:
in the step of water quality treatment, quicklime is not adopted for treating the nursery pond and the culture pond, but a large amount of traditional Chinese medicine components are respectively added during disinfection of the nursery pond and the culture pond, wherein aloe, ginkgo, gardenia, pigeon feces and pomegranate rind have the functions of killing insects and disinfecting, and a single traditional Chinese medicine component can inhibit the growth and reproduction of some or certain pathogenic bacteria or parasites, but the inhibition range is limited; in addition, traditional Chinese medicine components are added into the culture pond, wherein garlic, gardenia, fructus ulmi, bitter bamboo leaves and dogbane leaves have insecticidal effects, the insecticidal and bacteriostatic abilities are greatly improved when the traditional Chinese medicine components are used, and meanwhile, the bitter bamboo leaves and the fructus ulmi have the effects of killing insects, attracting food and promoting digestion, so that the growth of crabs is accelerated; a large amount of traditional Chinese medicine components are added in the water quality treatment process, the crab feed has the functions of disinfection and sterilization and nutrition, has the advantages of pure nature, no residue, small toxic and side effects, no pollution and various performances, and improves the survival rate and the quality of crabs.
The detailed conditions of the traditional Chinese medicine raw materials in the invention are as follows:
the efficacy and effect of aloe: 1. people with health-care physique can not only prevent and treat various diseases, but also improve physique, enhance physical strength and keep energy vigorous by taking aloe and adhering to an aloe bath. The body fluid of healthy people is alkalescent, becomes acidic due to overwork or life tension and is susceptible to virus infection, and the body fluid is kept alkaline due to the common use of the aloe vera, so that the healthy people can be kept and do not catch cold. 2. The aloe tincture with antibacterial effect is a substance with strong antibacterial effect, and can kill various fungi, mold, bacteria, viruses, etc., and inhibit and eliminate the development and reproduction of pathogens. 3. Anti-inflammatory bradykinin enzymes of aloe vera in combination with vascular tone counteract inflammation. Especially Aloe polysaccharides can enhance disease resistance, and can be used for treating chronic diseases such as dermatitis, chronic nephritis, cystitis, and bronchitis. 4. The aloe polysaccharide and vitamins have good nourishing, moistening and whitening effects on human skin. Especially the most annoying acne of young adolescents, aloe has good effect of eliminating acne. Aloe-emodin, etc. belongs to anthraquinone glycoside substance, which can make hair soft and glossy, relaxed and comfortable, and has dandruff removing effect. Therefore, aloe cosmetics such as aloe cosmetic cream, aloe skin cream, aloe hair dye cream, etc. account for 80% of the european cosmetics market. 5. The effective components of aloe-emodin glycoside and aloe-emodin in aloe for invigorating stomach and promoting diarrhea play a role in stimulating appetite and relieving diarrhea in large intestine. The aloe can strengthen the stomach function, strengthen the physique and restore the appetite of the patient suffering from loss of appetite due to weak physique after being taken. Aloe is the most effective medicine for treating constipation in ancient and modern countries, and can relieve constipation within 8-12 hours even after aloe is taken, because the aloin component increases the secretion of large intestine liquid, increases the activity of lipase and restores the disordered large intestine autonomic nerve function, and has no side effect or drug dependence. 6. The aloe vera calcium isocitrate with effects of tonifying heart and promoting blood circulation has effects of tonifying heart, promoting blood circulation, softening and hardening arteries, reducing cholesterol content, dilating capillary vessels, smoothing blood circulation, reducing cholesterol value, relieving heart burden, keeping blood pressure normal, and removing "toxin" in blood. 7. The aloin A, the wound hormone, the polypeptide mannan (Ke-2) and the like for promoting the wound healing have the functions of resisting virus infection and promoting the wound healing and recovery, have the functions of diminishing inflammation and sterilizing, absorbing heat and reducing swelling, softening skin and keeping cell activity, and the curdlan and the callus acid have the wound healing activity, so the curdlan is an ideal medicine for treating the trauma (hemorrhagic trauma and non-hemorrhagic trauma) without leaving scars. 8. The viscous polysaccharide in aloe for immunity and tumor resistance has the functions of improving immunity, inhibiting and destroying abnormal cell growth, and thus can reach the aim of resisting cancer. 9. The aloe has no toxicity, harm and side effects, and does not produce antibody. The aloe components such as aloetin alomicin have the effects of decomposing harmful substances in organism and eliminating toxin invading from organism. The radiation or nuclear radiation can treat burn skin ulcer caused by cancer, and Aloe has effects of removing toxic substance, relieving inflammation, regenerating new cell, and increasing leukocyte reduced by radiotherapy. 10. Anti-aging mucilage (protein) in Aloe vera is prepared from polysaccharides such as arboran A Baloe mannanase as core ingredient, and is important for preventing cell aging and treating chronic allergy. Mucin exists in human muscle and gastrointestinal mucosa, and makes the tissue elastic, and if insufficient mucin is available, the muscle and mucosa lose elasticity and become rigid and aging. If the mucin is insufficient, the cells constituting the human body are gradually weakened and lose the capability of defending germs and viruses. In addition, mucin has body strengthening and essence strengthening effects. 11. Analgesic and sedative effects when finger swelling and pain, toothache are intolerable, pain, neuralgia, gout, muscle and tendon pain can be eliminated by sticking aloe leaves on the affected part, and the aloe can be orally taken or externally applied to achieve analgesic effect. Aloe can also be used for preventing and treating hangover, carsickness, and seasickness. 12. The natural anthraquinone glycoside or anthracene derivative in aloe has sunscreen effect, and can absorb ultraviolet ray and prevent skin red and brown spot. 13. The aloe juice has good effects of disinfection and antisepsis. In summer, aloe juice is applied to the skin, and mosquitoes can not bite the aloe juice. Columbia often applies aloe juice to the feet of children to prevent insect damage. The aloe juice is sprayed to doors, windows and rooms, flies cannot enter the doors, windows and rooms, and the Dai nationality people use the aloe juice to prevent the flies from entering the rooms. 14. Deodorant effect Aloe has the effect of preventing foot, mouth, and armpit etc. body odor. Aloe vera has been used for long time to eliminate body odor.
Gingko, nature and taste, sweet, bitter, flat and astringent; the main treatment is uncooked food, malnutrition induced drinking and alcohol effect dispelling, and cooked food and people benefited (Lipengfei). Cooked food, warm lung and replenish qi, relieve dyspnea and cough, reduce stool and stop whitish and turbid. Raw meal, reducing phlegm, disinfection and disinsection. Chewing the pulp, spreading on the nose, face, hands and feet, removing wrinkles, and treating scabies, tinea, eczema, and pubic louse.
The pigeon feces are the highest nutritive value of all conventional livestock and poultry feces, and because the pigeon intestines are too short compared with cattle, sheep, goose and pig, and the food stays in the intestines for a short time, the nutrient of the pigeon feed can be absorbed by about one third of the pigeon intestine, most of pigeon feed is discharged from the body through the rectum, and finally the pigeon is pulled out. Pigeon manure contains about 28% of crude protein, 13% of pure protein and 8% of total amino acids, and various amino acids are relatively balanced, and in addition, the pigeon manure also contains rich B vitamins and various trace elements. Therefore, the pigeon manure is low-cost low-energy protein feed, part of the protein feed is replaced by the pigeon manure, and energy feed is supplemented, so that the economic benefit of the animal husbandry industry can be greatly improved, the pollution can be reduced, the environment can be purified, and an ecological industrial chain is formed. Likewise, the pigeon manure can be prepared into high-grade high-quality organic fertilizer through fermentation or further prepared into organic and inorganic biological formula fertilizer (referred to as biological fertilizer for short), thereby bringing good economic, ecological and social benefits. For example, the fermented feed can reach 200 tons when 41.4 kilograms of fresh excrement is produced per pigeon every year and 414 tons of fresh excrement is produced in ten thousand pigeon farms every year, and if the feed is completely used by oneself, the cost of about 16 ten thousand yuan of feed can be saved, and if the feed is sold, the economic income of 24 ten thousand yuan can be generated. But if the fresh manure is not fermented, the fresh manure can be directly sold to obtain about 6 ten thousand yuan, and compared with the two phases, the economic return of fermentation is obvious. With the large-scale feeding, the utilization value of the pigeon manure is higher and higher, the nutrient content of the pigeon manure feed after processing is not lower than that of other livestock manure, and in addition, the pigeon manure feed has the effect of preventing certain diseases when being used for feeding livestock.
Gardenia, nature and taste, bitter and cold; the indications include five internal pathogenic factors, stomach heat, red face, red wine, nasal obstruction, pellagra, scabies and sores (Benjing). Treating conjunctival congestion, heat pain, chest, heart, large and small intestine large heat, and vexation in heart (Bian Lu). Removing toxic heat and wind, removing seasonal fever, relieving five kinds of jaundice, benefiting five kinds of stranguria, inducing diuresis, quenching thirst, improving eyesight, treating aversion to heat, and killing parasites (right to screen). Relieving jade dominance of hoarseness and purpura. For restlessness, insomnia, dysuria due to blood stagnation under umbilicus. Purging triple energizer fire, clearing stomach and blood, treating heat syncope and heart pain, relieving heat stagnation and moving qi (Shaheng). It is indicated for hematemesis, epistaxis, bloody dysentery, stranguria with blood, blood stasis, typhoid fever, fatigue, headache, hernia, scald, fire injury (Shizhen).
Pomegranate rind, sour, astringent, warm; function, astringent soup: can be used for treating chronic diarrhea and dysentery. (2) Killing insects: can be used for killing tapeworm and roundworm.
Fructus Ulmus Preparatium, pungent, bitter, warm; indications, killing parasites and eliminating malnutrition: can be used for killing ascarid and tapeworm and treating malnutritional stagnation. It can be used for treating ascariasis and enterobiasis.
Bitter bamboo leaves, nature and taste, bitter taste and cold; efficacy, aphtha, eye pain, improving eyesight and inducing resuscitation (Bian Lu). Treating insomnia, quenching thirst, relieving alcoholism, removing dysphoria, sweating, and treating aphonia due to apoplexy. Killing pests. Mixing with fel Sus Domestica, and applying to treat infantile head sore, ear sore, scabies and tinea; it is often used to take effect when mixing with chicken egg white to treat all malignant sores.
Folium apocyni veneti has the following pharmacological effects: 1. the apocynum venetum leaf decoction for reducing blood pressure reduces the blood pressure from 194/142mm Hg to 152/100mm Hg after 2 hours after gastric lavage of the kidney type hypertensive dog, and is stable at a lower level all the time, and the blood pressure rises after 3 days. 2. Canada hemp glycoside contained in apocynum venetum root has cardiotonic effect, and can make the isolated and in-situ cat heart increase its contraction amplitude, slow down heart rate, and then make the heart rhythm be irregular, and finally make the heart beat stop in contraction period, its action property and speed are similar to that of Convolvulus glycoside, and the central inhibitory medicine of pentobarbital sodium can reduce its cardiotonic effect. The dogbane root extract is used for carrying out experiments on the heart of the cat, and also shows a cardiac glycoside-like effect. Plants of the same genus (e.g., Apocynum canadensis) are less effective than digitalis in patients with atrial fibrillation, e.g., in doses sufficient to control cardiac rhythm disturbances, often causing nausea, vomiting, diarrhea. 3. The Canada hemp glycoside has better effect than Convolvulin in treating canine experimental cardiovascular insufficiency, alleviating the symptoms of acute circulatory disturbance of rabbit myocarditis, and preventing myocardial and coronary angiosclerosis. It can restore normal electrocardiogram change of atherosclerotic rabbit, has remarkable effect on coronary contraction, and has therapeutic effect on atherosclerosis due to deficiency of rabbit coronary circulation function caused by pituitrin and thrombin, but is weak. Can increase cardiac glycogen resynthesis. [ in use, hyperlipidemia was not effective in mice fed with high-fat diet; it is proved that the dogbane leaf has the function of reducing the endogenous blood fat. 4. The radiation damage resistant apocynum venetum leaf extract is subjected to intragastric administration at the concentration of 2g/kg and intraperitoneal injection at the concentration of 0.5g/kg for 15-20 consecutive days, so that the survival days of mice irradiated by 60Co gamma-rays can be prolonged, the survival rate is increased, the number of blood leucocytes is increased, the same effect is also achieved when the quercetin is subjected to intragastric administration at the concentration of 30mg/kg, and the radiation resistant effect of the apocynum venetum leaf is considered to be related to the quercetin. 5. The function of the spleen that triacontanol has no obvious influence on the growth of normal young mice; has weight increasing effect on spleen of mouse, and is especially significant when injected intramuscularly at 20 mg/kg; the influence on the thymus of the mice is inconsistent, the thymus of the adult mice is slightly increased, and the weight of the young mice is slightly reduced; has obvious resistance to weight loss of spleen and thymus caused by cyclophosphamide; has effect in enhancing phagocytic function of macrophage in abdominal cavity of mouse. 6. Action on cardiovascular system Apocynum venetum extract water filtrate (10%) is injected into anaesthetized dog vein at constant speed (2.0ml/kg, 3.6ml/min), and blood pressure is reduced. Over 7 minutes) up to a maximum of 22.3%, a drop in blood pressure accompanied by a slowing of the heart rate (r 0.83) which lasts for 30 minutes since the administration. Blood pressure decreases with decreased cardiac output, cardiac index, cardiac beat index and coronary left circumflex blood flow. Has no influence on the load before and after the heart. Myocardial oxygen consumption decreased within 3 minutes of intravenous injection. Intravenous injection of herba Apocyni Veneti leaf decoction (0.25g/kg) or its flavonoid glycoside (10-15mg/kg) into dog can reduce heart rate after 1-10 min, recover after 30 min, and increase dosage to 1g/kg and flavonoid glycoside to 20mg/kg can cause arrhythmia, ST segment depression, and T wave deformation, which indicates that both can cause cardiotoxic reaction. Intravenous injection of dogbane leaf flavonoid glycoside for dog and cat can lower blood pressure by 12.6-36.7%; the antihypertensive effect is maintained for 3-10 minutes after one-time administration, but the fast tolerance exists, and the blood pressure can be reduced when 5g/kg of the apocynum venetum leaf decoction (1.5.10g/kg) is taken for the experimental renal hypertension dogs. The dose can be reduced from 194/142 to 152/100mmHg after 2 hours, and the dose can be increased after three days. The flavonoid glycoside has obvious effect of dilating blood vessels when perfusing isolated rabbit ear blood vessels with 5mg each time. 7. Diuresis inducing effect the dogbane leaf water extract and the burning residue of the extract have diuresis inducing effect, the total urine output of rats 6-24 hours and 24 hours after the dogbane leaf water extract is orally taken by the rats is respectively increased by 50.60% and 32.28%, and the urine sodium and urine potassium output is correspondingly increased, but the urine potassium and urine sodium concentrations of an administration group and a control group are not obviously different. After the apocynum venetum leaf water extract is injected into a home-free intravenous injection for 30 minutes, the urine volume is obviously increased (the urine volume is increased between 28.96 and 106.20 percent), the effect lasts for more than 2 hours, the output of natrium and potassium in urine is not obviously increased (the output of potassium in urine is increased within 2 hours), and the concentrations of natrium and potassium in urine are lower than the levels before administration. After dog is injected with dogbane leaf water extract intravenously, the urine volume at each time phase within 60 minutes is obviously increased, the output of natrium and potassium in urine is correspondingly increased, but the concentrations of natrium and potassium in urine are lower than the level before administration. The burning residue of the dogbane leaf extract has a quick and strong diuretic effect on rabbits, but the action duration is shorter than that of the extract. 8. The dogbane leaf water extract can obviously reduce the serum total cholesterol value and the triglyceride value of a rat with hyperlipidemia caused by Triton, but cannot reduce the cholesterol value of the mouse with hypercholesterolemia caused by high-fat feed. 9. The folium Apocyni Veneti extract has antiaging or life prolonging effects on Drosophila melanogaster, Bombyx mori, and mouse. The dogbane leaf extract has the effect of reducing the content of lipofuscin in the internal organs of mice to different degrees, and can generally improve the activity of superoxide dismutase (SOD) of the liver and the heart of the mice of different age groups. Apocynum venetum tea can increase SOD value and HDL-e in erythrocytes, and is beneficial for preventing arteriosclerosis. Chemical components: the leaves contain quercetin (quercetin), isoquercitrin (iso-quercitrin), hyperoside (hyperide), rutin (rutin), d-catechin (catechin), enquinone (antraquinone), glutamic acid (glutaminic acid), alanine (alanine), valine (valine), various amino acids, nonacosane (nona-cosane), triacontanol (1-triacontanol), hentriacontanol (hentriacontane), lupeol palmitate (lupenyl palmitate), myricyl palmitate (myricyl palmitate), hexadecanol palmitate (hexadecanol palmitate), meso-inositol (meso-inositol), beta-sitosterol (beta-sitosterol), potassium chloride, tannin and polysaccharide, lupeol (lupeol), isobutanol (isoniadine), and scopolamine (scopolamine). The root contains Canadian hemp glycoside (cymarin), K-stro-phanthin-beta and strophanthin aglycone (strophanthin).
The Glycyrrhrizae radix contains multiple chemical components, such as glycyrrhizic acid and liquiritin. The chemical composition of licorice is very complex, and there are dozens of compounds separated from licorice so far, such as glycyrrhizin, glycyrrhetinic acid, liquiritin, isoliquiritin, neoliquiritin, neoisoliquiritin, liquiritigenin, and glycyrrhizin, glycyrol, isoliquiritigenin, 7-methyl coumarine, umbelliferone, etc., but these components and amounts usually vary depending on factors such as the type of licorice, the planting area, the harvesting time, etc. A large number of researches show that glycyrrhizin and flavonoids are the most important physiological active substances in liquorice and mainly exist in the part inside the epidermis of liquorice root.
Selfheal, pungent, bitter and cold in nature and flavor; meridian tropism, liver meridian and gallbladder meridian tropism; has the main functions of clearing fire, improving eyesight, eliminating stagnation and reducing swelling. Can be used for treating conjunctival congestion, swelling and pain, eyeball nyctalgia, headache, giddiness, scrofula, goiter, mammary abscess, and swelling and pain; goiter, tuberculous lymphadenitis, hyperplasia of mammary glands, and hypertension.
Ku Shen is bitter and cold. Has the functions of clearing heat, drying dampness, killing parasites and promoting urination. Can be used for treating dysentery with heat, hematochezia, jaundice, anuria, leucorrhea with red and white discharge, pudendal swelling, pudendal pruritus, eczema, skin pruritus, scabies, tinea, leprosy, and trichomonas vaginitis.
Loranthus mulberry mistletoe, bitter and sweet in nature and taste, mild in flavor; entering meridians, entering liver and kidney meridians; has the main functions of nourishing liver and kidney, strengthening bones and muscles, removing rheumatism, dredging channels and collaterals, benefiting blood and preventing miscarriage. It is used to treat soreness of waist and knees, atrophy and weakness of tendons and bones, hemiplegia, tinea pedis, arthralgia due to wind-cold-dampness, fetal leakage, metrorrhagia, and puerperal agalactia. It is indicated for chronic cough, longitudinal vertigo of tongue.
Chinese angelica, nature and taste, sweet, pungent and warm; meridian tropism, liver, heart and spleen meridians; the function is mainly used for enriching blood; promoting blood circulation; regulating menstruation and relieving pain; moistening dryness and smoothing intestine. The main symptoms are blood deficiency; menoxenia; amenorrhea; dysmenorrhea; the accumulation of symptoms; (ii) metrorrhagia and metrostaxis; abdominal pain due to deficiency-cold; flaccidity and paralysis; numbness of the skin; intestinal dryness and difficult defecation; severe dysentery with diarrhea; carbuncle, cellulitis, sore and ulcer; injury from falling.
Bupleurum root, nature and taste, pungent; slightly cold in nature; meridian tropism, liver tropism; gallbladder meridian; the efficacy and the effect are as follows: harmonize exterior and interior, soothe liver and raise yang. It is used to treat alternating cold and heat, fullness in chest, hypochondriac pain, bitter taste in mouth, deafness, headache, blurred vision, malaria, prolapse of anus, menoxenia, and metroptosis.
Cortex acanthopanacis, pungent, bitter and warm in nature; meridian tropism, liver and kidney meridians; has the main functions of expelling wind-damp, nourishing liver and kidney and strengthening bones and muscles. Can be used for treating rheumatalgia, tendons and bones flaccidity, infantile retardation, asthenia, edema, and tinea pedis.
Motherwort herb is pungent, bitter and cool in property and taste, and has the functions of promoting blood circulation, removing blood stasis, regulating menstruation and eliminating water, and is used in treating female menoxenia, vaginal bleeding, abdominal pain, etc.
Dandelion, nature and taste, bitter and sweet, cold; entering meridians, entering liver and stomach meridians; has the main functions of clearing away heat and toxic materials, promoting urination and resolving masses. It can be used for treating acute mastitis, lymphadenitis, lymphoid tuberculosis, furunculosis, acute conjunctivitis, common cold with fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
[ detailed description ] embodiments
The following examples may assist those skilled in the art in a more complete understanding of the present invention, but are not intended to limit the invention in any way.
Example 1:
a natural cultivation method of river crabs comprises the following steps:
1) establishing a pond: is divided into a seedling raising pond and a culture pond; wherein,
a seedling raising pond: selecting a place with sufficient water source, convenient water inlet and drainage, good water quality, no pollution and good air permeability, wherein the area is 0.5-1 mu, the gradient ratio is 0.5: 1-2, a crab ditch with the depth of 0.3-0.4 m and the width of 1-2 m is dug in the pool, anti-escape walls with the height of 50-60 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the pool is 30-40 cm, and the water level of a deep water area is 60-70 cm; the water inlet and the water outlet are both provided with round holes with the diameter of 10-15 cm, and are both provided with a filter screen with the mesh of 50-70; the method comprises the following steps of planting tape grass, alternanthera philoxeroides and red eggs in a pond according to the water plant coverage rate of 50-60%, throwing small stones with the total height of 5-10 cm and the diameter of 2-8 cm, and putting 5-8 kg of peat soil in each mu;
a culture pond: the area of the crab ditch is 2-3 mu, the slope is 1: 2-2.5, crab ditches with the depth of 1-1.5 m and the width of 4-5 m are dug in the crab ditch, escape-preventing walls with the height of 60-70 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the culture pond is 60-70 cm, and the water level of a deep water area is 100-120 cm; the water inlet and the water outlet are both provided with circular holes with the diameter of 12-17 cm and are both provided with 80-100 mesh filter screens; the method is characterized in that hydrilla verticillata, water hyacinth, chlorophyta and green chrysanthemum are used as main materials in the pond, the grass consumption per mu is 13-16kg, the row spacing is 0.8-1m, stones with the total height of 8-12 cm and the diameter of 5-9 cm are thrown in the pond, and in addition, 10-20 kg of peat soil is thrown in each mu;
2) crab larva selection: crab seedlings with the weight of 50-80 g, consistent specification, consistent body color and strong activity;
3) water quality treatment: and (3) sprinkling 90-110 kg of traditional Chinese medicine mixed powder I for disinfection per mu 12-15 days before crab larvae are put in the nursery pond, and keeping the water temperature at 18-25 ℃, wherein the traditional Chinese medicine mixed powder I is formed by crushing the following raw materials in parts by weight: 1 part of aloe powder, 2 parts of ginkgo, 0.2 part of pigeon manure, 1 part of gardenia and 0.1 part of pomegranate bark;
a culture pond: every 10-15 days, taking the following raw materials, namely 1 part of garlic, 1 part of gardenia, 0.1 part of fructus ulmi, 0.2 part of bitter bamboo leaf and 0.1 part of apocynum venetum leaf, and crushing to obtain traditional Chinese medicine mixed powder II; then, spraying 120-140 kilograms of traditional Chinese medicine mixed powder II per mu for disinfection, and keeping the water temperature at 20-25 ℃;
4) seedling releasing: before seedling release, potassium permanganate with the concentration of 2% is used for 10-15 g/m3Soaking the solution for 2-3 minutes, then putting the solution into clear water for 8-10 minutes, repeating the soaking for 2-3 times, then putting the disinfected crab seedlings into a seedling pool for 10-20 crab seedlings per time, and after all the crab seedlings are slowly scattered, then putting the rest crab seedlings into the seedling pool in the manner;
5) adding water and changing water treatment: the seedling raising pond is changed every 10 days to keep the water quality transparency of the shallow water area above 20cm and the water quality transparency of the deep water area above 50 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 35cm and the average water level of the deep water area at 65 cm;
a culture pond: changing water every 5-8 days to keep the water quality transparency of the shallow water area above 50cm and the water quality transparency of the deep water area above 80 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 65cm and the average water level of the deep water area at 110 cm;
6) bait casting management:
a) the first stage is as follows: feeding twice with bait I1-10 days after the crab larvae are placed in a nursery pond, wherein each bait I is 0.01-0.02 time of the weight of the crab larvae, and comprises the following components: soybean starch, dried snail meat, sweet potato powder and a Chinese herbal medicine additive I, wherein the Chinese herbal medicine additive I is prepared from the following raw materials: 0.1 to 0.3 portion of liquorice, 0.2 to 0.4 portion of selfheal, 0.2 to 0.4 portion of lightyellow sophora root, 0.05 to 0.07 portion of Chinese taxillus twig, 0.02 to 0.04 portion of Chinese date, 0.02 to 0.04 portion of Chinese angelica and 0.01 to 0.03 portion of Chinese lobelia;
b) and a second stage: feeding the crabs for 11-20 days after the crabs are placed in a nursery pond for three times every day by adopting bait II, wherein each bait II is 0.07-0.09 time of the weight of the crabs, and comprises the following components: corn starch, screw meat, fish meal and a traditional Chinese medicine additive II, wherein the traditional Chinese medicine additive II is prepared from the following raw materials: 0.2-0.3 part of radix bupleuri, 0.02-0.04 part of cortex acanthopanacis, 0.03-0.06 part of motherwort, 0.1-0.4 part of wild chrysanthemum flower, 0.2-0.4 part of dandelion and 0.1-0.2 part of mint, and the traditional Chinese medicine additive II is put into a grinder to be ground and then passes through a 10-30 mesh screen;
c) and a third stage: feeding the crabs for three times every day by adopting bait II within 5 months after the crabs are transferred from the nursery pond to the culture pond, wherein each crab is fed according to 0.1-0.3 time of the weight of the crab;
d) a fourth stage: after 5 months of transferring the crabs from the nursery pond to the culture pond, feeding the crabs for three times every day by using bait III, wherein each bait III is 0.5 time of the weight of the crab, and comprises the following components: chicken, egg shell powder, meat and bone powder, vitamins and bone powder.
Example 2
A natural cultivation method of river crabs comprises the following steps:
1) establishing a pond: is divided into a seedling raising pond and a culture pond; wherein,
a seedling raising pond: selecting a place with sufficient water source, convenient water inlet and drainage, good water quality, no pollution and good air permeability, wherein the area is 0.5-1 mu, the gradient ratio is 0.5: 1-2, a crab ditch with the depth of 0.3-0.4 m and the width of 1-2 m is dug in the pool, anti-escape walls with the height of 50-60 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the pool is 30-40 cm, and the water level of a deep water area is 60-70 cm; the water inlet and the water outlet are both provided with round holes with the diameter of 10-15 cm, and are both provided with a filter screen with the mesh of 50-70; the method comprises the following steps of planting tape grass, alternanthera philoxeroides and red eggs in a pond according to the water plant coverage rate of 50-60%, throwing small stones with the total height of 5-10 cm and the diameter of 2-8 cm, and putting 5-8 kg of peat soil in each mu;
a culture pond: the area of the crab ditch is 2-3 mu, the slope is 1: 2-2.5, crab ditches with the depth of 1-1.5 m and the width of 4-5 m are dug in the crab ditch, escape-preventing walls with the height of 60-70 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the culture pond is 60-70 cm, and the water level of a deep water area is 100-120 cm; the water inlet and the water outlet are both provided with circular holes with the diameter of 12-17 cm and are both provided with 80-100 mesh filter screens; the method is characterized in that hydrilla verticillata, water hyacinth, chlorophyta and green chrysanthemum are used as main materials in the pond, the grass consumption per mu is 13-16kg, the row spacing is 0.8-1m, stones with the total height of 8-12 cm and the diameter of 5-9 cm are thrown in the pond, and in addition, 10-20 kg of peat soil is thrown in each mu;
2) crab larva selection: crab seedlings with the weight of 50-80 g, consistent specification, consistent body color and strong activity;
3) water quality treatment: and (3) sprinkling 90-110 kg of traditional Chinese medicine mixed powder I for disinfection per mu 12-15 days before crab larvae are put in the nursery pond, and keeping the water temperature at 18-25 ℃, wherein the traditional Chinese medicine mixed powder I is formed by crushing the following raw materials in parts by weight: 1.5 parts of aloe powder, 2 parts of ginkgo, 0.3 part of pigeon manure, 15 parts of gardenia and 0.2 part of pomegranate bark;
a culture pond: every 10-15 days, taking the following raw materials, namely 1.5 parts of garlic, 1.5 parts of gardenia, 0.2 part of fructus ulmi, 0.3 part of bitter bamboo leaf and 0.2 part of apocynum venetum leaf, and crushing to obtain traditional Chinese medicine mixed powder II; then, spraying 120-140 kilograms of traditional Chinese medicine mixed powder II per mu for disinfection, and keeping the water temperature at 20-25 ℃ and the turbidity of the water less than 10%;
4) seedling releasing: before seedling release, potassium permanganate with the concentration of 4 percent is used for 10-15 g/m3Soaking the solution for 2-3 minutes, then putting the solution into clear water for 8-10 minutes, repeating the soaking for 2-3 times, then putting the disinfected crab seedlings into a seedling pool for 10-20 crab seedlings per time, and after all the crab seedlings are slowly scattered, then putting the rest crab seedlings into the seedling pool in the manner;
5) adding water and changing water treatment: the seedling raising pond is changed every 10 days to keep the water quality transparency of the shallow water area above 20cm and the water quality transparency of the deep water area above 50 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 35cm and the average water level of the deep water area at 65 cm;
a culture pond: changing water every 5-8 days to keep the water quality transparency of the shallow water area above 50cm and the water quality transparency of the deep water area above 80 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 65cm and the average water level of the deep water area at 110 cm;
6) bait casting management:
a) the first stage is as follows: feeding twice with bait I1-10 days after the crab larvae are placed in a nursery pond, wherein each bait I is 0.01-0.02 time of the weight of the crab larvae, and comprises the following components: soybean starch, dried snail meat, sweet potato powder and a Chinese herbal medicine additive I, wherein the Chinese herbal medicine additive I is prepared from the following raw materials: 0.1 to 0.3 portion of liquorice, 0.2 to 0.4 portion of selfheal, 0.2 to 0.4 portion of lightyellow sophora root, 0.05 to 0.07 portion of Chinese taxillus twig, 0.02 to 0.04 portion of Chinese date, 0.02 to 0.04 portion of Chinese angelica and 0.01 to 0.03 portion of Chinese lobelia;
b) and a second stage: feeding the crabs for 11-20 days after the crabs are placed in a nursery pond for three times every day by adopting bait II, wherein each bait II is 0.07-0.09 time of the weight of the crabs, and comprises the following components: corn starch, screw meat, fish meal and a traditional Chinese medicine additive II, wherein the traditional Chinese medicine additive II is prepared from the following raw materials: 0.2-0.3 part of radix bupleuri, 0.02-0.04 part of cortex acanthopanacis, 0.03-0.06 part of motherwort, 0.1-0.4 part of wild chrysanthemum flower, 0.2-0.4 part of dandelion and 0.1-0.2 part of mint, and the traditional Chinese medicine additive II is put into a grinder to be ground and then passes through a 10-30 mesh screen;
c) and a third stage: feeding the crabs for three times every day by adopting bait II within 5 months after the crabs are transferred from the nursery pond to the culture pond, wherein each crab is fed according to 0.1-0.3 time of the weight of the crab;
d) a fourth stage: after 5 months of transferring the crabs from the nursery pond to the culture pond, feeding the crabs for three times every day by using bait III, wherein each bait III is 0.5 time of the weight of the crab, and comprises the following components: chicken, egg shell powder, meat and bone powder, vitamins and bone powder.
Example 3
A natural cultivation method of river crabs comprises the following steps:
1) establishing a pond: is divided into a seedling raising pond and a culture pond; wherein,
a seedling raising pond: selecting a place with sufficient water source, convenient water inlet and drainage, good water quality, no pollution and good air permeability, wherein the area is 0.5-1 mu, the gradient ratio is 0.5: 1-2, a crab ditch with the depth of 0.3-0.4 m and the width of 1-2 m is dug in the pool, anti-escape walls with the height of 50-60 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the pool is 30-40 cm, and the water level of a deep water area is 60-70 cm; the water inlet and the water outlet are both provided with round holes with the diameter of 10-15 cm, and are both provided with a filter screen with the mesh of 50-70; the method comprises the following steps of planting tape grass, alternanthera philoxeroides and red eggs in a pond according to the water plant coverage rate of 50-60%, throwing small stones with the total height of 5-10 cm and the diameter of 2-8 cm, and putting 5-8 kg of peat soil in each mu;
a culture pond: the area of the crab ditch is 2-3 mu, the slope is 1: 2-2.5, crab ditches with the depth of 1-1.5 m and the width of 4-5 m are dug in the crab ditch, escape-preventing walls with the height of 60-70 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the culture pond is 60-70 cm, and the water level of a deep water area is 100-120 cm; the water inlet and the water outlet are both provided with circular holes with the diameter of 12-17 cm and are both provided with 80-100 mesh filter screens; the method is characterized in that hydrilla verticillata, water hyacinth, chlorophyta and green chrysanthemum are used as main materials in the pond, the grass consumption per mu is 13-16kg, the row spacing is 0.8-1m, stones with the total height of 8-12 cm and the diameter of 5-9 cm are thrown in the pond, and in addition, 10-20 kg of peat soil is thrown in each mu;
2) crab larva selection: crab seedlings with the weight of 50-80 g, consistent specification, consistent body color and strong activity;
3) water quality treatment: and (3) sprinkling 90-110 kg of traditional Chinese medicine mixed powder I for disinfection per mu 12-15 days before crab larvae are put in the nursery pond, and keeping the water temperature at 18-25 ℃, wherein the traditional Chinese medicine mixed powder I is formed by crushing the following raw materials in parts by weight: 2 parts of aloe powder, 3 parts of ginkgo, 0.4 part of pigeon manure, 2 parts of gardenia and 0.3 part of pomegranate bark;
a culture pond: every 10-15 days, taking and crushing the following raw materials to obtain traditional Chinese medicine mixed powder II, namely 2 parts of garlic, 2 parts of cape jasmine, 0.3 part of fructus ulmi, 0.4 part of bitter bamboo leaf and 0.3 part of apocynum venetum leaf; then, spraying 120-140 kilograms of traditional Chinese medicine mixed powder II per mu for disinfection, and keeping the water temperature at 20-25 ℃ and the turbidity of the water less than 10%;
4) seedling releasing: before seedling release, potassium permanganate with the concentration of 5 percent is used for 10-15 g/m3Soaking the solution for 2-3 minutes, then putting the solution into clear water for 8-10 minutes, repeating the soaking for 2-3 times, then putting the disinfected crab seedlings into a seedling pool for 10-20 crab seedlings per time, and after all the crab seedlings are slowly scattered, then putting the rest crab seedlings into the seedling pool in the manner;
5) adding water and changing water treatment: the seedling raising pond is changed every 10 days to keep the water quality transparency of the shallow water area above 20cm and the water quality transparency of the deep water area above 50 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 35cm and the average water level of the deep water area at 65 cm;
a culture pond: changing water every 5-8 days to keep the water quality transparency of the shallow water area above 50cm and the water quality transparency of the deep water area above 80 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 65cm and the average water level of the deep water area at 110 cm;
6) bait casting management:
a) the first stage is as follows: feeding twice with bait I1-10 days after the crab larvae are placed in a nursery pond, wherein each bait I is 0.01-0.02 time of the weight of the crab larvae, and comprises the following components: soybean starch, dried snail meat, sweet potato powder and a Chinese herbal medicine additive I, wherein the Chinese herbal medicine additive I is prepared from the following raw materials: 0.1 to 0.3 portion of liquorice, 0.2 to 0.4 portion of selfheal, 0.2 to 0.4 portion of lightyellow sophora root, 0.05 to 0.07 portion of Chinese taxillus twig, 0.02 to 0.04 portion of Chinese date, 0.02 to 0.04 portion of Chinese angelica and 0.01 to 0.03 portion of Chinese lobelia;
b) and a second stage: feeding the crabs for 11-20 days after the crabs are placed in a nursery pond for three times every day by adopting bait II, wherein each bait II is 0.07-0.09 time of the weight of the crabs, and comprises the following components: corn starch, screw meat, fish meal and a traditional Chinese medicine additive II, wherein the traditional Chinese medicine additive II is prepared from the following raw materials: 0.2-0.3 part of radix bupleuri, 0.02-0.04 part of cortex acanthopanacis, 0.03-0.06 part of motherwort, 0.1-0.4 part of wild chrysanthemum flower, 0.2-0.4 part of dandelion and 0.1-0.2 part of mint, and the traditional Chinese medicine additive II is put into a grinder to be ground and then passes through a 10-30 mesh screen;
c) and a third stage: feeding the crabs for three times every day by adopting bait II within 5 months after the crabs are transferred from the nursery pond to the culture pond, wherein each crab is fed according to 0.1-0.3 time of the weight of the crab;
d) a fourth stage: after 5 months of transferring the crabs from the nursery pond to the culture pond, feeding the crabs for three times every day by using bait III, wherein each bait III is 0.5 time of the weight of the crab, and comprises the following components: chicken, egg shell powder, meat and bone powder, vitamins and bone powder.
To illustrate the effects of the present invention, comparative experiments were conducted using the following methods:
the invention group: inventive example 2 was used;
control group 1: the method is used in the embodiment 2, but in the step 3), quicklime is directly used for disinfecting the seedling raising pond in the water quality treatment;
control group 2: the method is used in the embodiment 2, but except for the step 3), quicklime is directly used for sterilizing the culture pond in the water quality treatment;
control group 3: the method is used in the embodiment 2, but in the step 3), quicklime is directly used for sterilizing the nursery ponds and the culture ponds in the water quality treatment;
the method provided by the invention is adopted to cultivate 500 river crabs for ten months in the embodiment 2 and the control groups 1-3, and the comparison results are observed and shown in the table 1:
TABLE 1 observations after ten months
Group of | Survival rate |
Invention group | 92.5% |
Control group 1 | 82.3% |
Control group 2 | 81.2% |
Control group 3 | 61.2% |
According to the invention, in the water quality treatment step, quicklime is not adopted for treating the nursery pond and the culture pond, but a large amount of traditional Chinese medicine components are respectively added during disinfection of the nursery pond and the culture pond, wherein aloe, ginkgo, gardenia, pigeon feces and pomegranate rind have the functions of killing insects and disinfecting, and a single traditional Chinese medicine component can inhibit the growth and reproduction of some or certain pathogenic bacteria or parasites, but the inhibition range is limited; in addition, traditional Chinese medicine components are added into the culture pond, wherein garlic, gardenia, fructus ulmi, bitter bamboo leaves and dogbane leaves have insecticidal effects, the insecticidal and bacteriostatic abilities are greatly improved when the traditional Chinese medicine components are used, and meanwhile, the bitter bamboo leaves and the fructus ulmi have the effects of killing insects, attracting food and promoting digestion, so that the growth of crabs is accelerated; the traditional Chinese medicine components are added in the water quality treatment process, so that the crab water quality treatment agent has the functions of disinfection and sterilization and nutrition, has the advantages of pure nature, no residue, small toxic and side effects, no pollution and various performances, and improves the survival rate and the quality of crabs.
Claims (7)
1. A natural cultivation method of river crabs is characterized in that: the natural culture method of the river crabs comprises the following steps:
1) establishing a pond: is divided into a seedling raising pond and a culture pond; wherein,
a seedling raising pond: selecting a place with sufficient water source, convenient water inlet and drainage, good water quality, no pollution and good air permeability, wherein the area is 0.5-1 mu, the gradient ratio is 0.5: 1-2, a crab ditch with the depth of 0.3-0.4 m and the width of 1-2 m is dug in the pool, anti-escape walls with the height of 50-60 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the pool is 30-40 cm, and the water level of a deep water area is 60-70 cm; the water inlet and the water outlet are both provided with round holes with the diameter of 10-15 cm, and are both provided with a filter screen with the mesh of 50-70; the method comprises the following steps of planting tape grass, alternanthera philoxeroides and red eggs in a pond according to the water plant coverage rate of 50-60%, throwing small stones with the total height of 5-10 cm and the diameter of 2-8 cm, and putting 5-8 kg of peat soil in each mu;
a culture pond: the area of the crab ditch is 2-3 mu, the slope is 1: 2-2.5, crab ditches with the depth of 1-1.5 m and the width of 4-5 m are dug in the crab ditch, escape-preventing walls with the height of 60-70 cm are built around the crab ditch, and plastic films are used as materials; the water level of a shallow water area in the culture pond is 60-70 cm, and the water level of a deep water area is 100-120 cm; the water inlet and the water outlet are both provided with circular holes with the diameter of 12-17 cm and are both provided with 80-100 mesh filter screens; the method is characterized in that hydrilla verticillata, water hyacinth, chlorophyta and green chrysanthemum are used as main materials in the pond, the grass consumption per mu is 13-16kg, the row spacing is 0.8-1m, stones with the total height of 8-12 cm and the diameter of 5-9 cm are thrown in the pond, and in addition, 10-20 kg of peat soil is thrown in each mu;
2) crab larva selection: crab seedlings with the weight of 50-80 g, consistent specification, consistent body color and strong activity;
3) water quality treatment: and (3) sprinkling 90-110 kg of traditional Chinese medicine mixed powder I for disinfection per mu 12-15 days before crab larvae are put in the nursery pond, and keeping the water temperature at 18-25 ℃, wherein the traditional Chinese medicine mixed powder I is formed by crushing the following raw materials in parts by weight: 1-2 parts of aloe powder, 2-3 parts of ginkgo, 0.2-0.4 part of pigeon manure, 1-2 parts of gardenia and 0.1-0.3 part of pomegranate bark;
a culture pond: every 10-15 days, taking the following raw materials to obtain traditional Chinese medicine mixed powder II: 1-2 parts of garlic, 1-2 parts of gardenia, 0.1-0.3 part of fructus ulmi, 0.2-0.4 part of bitter bamboo leaf and 0.1-0.3 part of apocynum venetum leaf; then, spraying 120-140 kilograms of traditional Chinese medicine mixed powder II per mu for disinfection, and keeping the water temperature at 20-25 ℃;
4) seedling releasing: before seedling release, potassium permanganate is used for 10-15 g/m3Soaking the crab seedlings in the solution for 2-3 minutes, then putting the crab seedlings into clear water for 8-10 minutes, repeating the soaking for 2-3 times, then putting the disinfected crab seedlings into a seedling culture pond according to 10-20 crab seedlings per time, and after all the crab seedlings are slowly scattered, then slowly dispersing the rest crab seedlingsPutting the crab seedlings into a seedling raising pond according to the mode;
5) adding water and changing water treatment: the seedling raising pond is changed every 10 days to keep the water quality transparency of the shallow water area above 20cm and the water quality transparency of the deep water area above 50 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 35cm and the average water level of the deep water area at 65 cm;
a culture pond: changing water every 5-8 days to keep the water quality transparency of the shallow water area above 50cm and the water quality transparency of the deep water area above 80 cm; adding water once in 2-3 days in summer to keep the average water level of the shallow water area at 65cm and the average water level of the deep water area at 110 cm;
6) bait casting management:
a) the first stage is as follows: feeding twice with bait I1-10 days after the crab larvae are placed in a nursery pond, wherein each bait I is 0.01-0.02 time of the weight of the crab larvae, and comprises the following components: soybean starch, dried snail meat, sweet potato powder and a traditional Chinese medicine additive I, wherein the traditional Chinese medicine additive I is prepared from the following raw materials: licorice, selfheal, radix sophorae flavescentis, parasitic loranthus, Chinese date, Chinese angelica and Chinese lobelia;
b) and a second stage: feeding the crabs for 11-20 days after the crabs are placed in a nursery pond for three times every day by adopting bait II, wherein each bait II is 0.07-0.09 time of the weight of the crabs, and comprises the following components: corn starch, screw meat, fish meal and a traditional Chinese medicine additive II, wherein the traditional Chinese medicine additive II is prepared from the following raw materials: the Chinese medicinal additive II is added into a grinder to be ground and then pass through a sieve of 10-30 meshes;
c) and a third stage: feeding the crabs for three times every day by adopting bait II within 5 months after the crabs are transferred from the nursery pond to the culture pond, wherein each crab is fed according to 0.1-0.3 time of the weight of the crab;
d) a fourth stage: after 5 months of transferring the crabs from the nursery pond to the culture pond, feeding the crabs for three times every day by using bait III, wherein each bait III is 0.5 time of the weight of the crab, and comprises the following components: chicken, egg shell powder, meat and bone powder, vitamins and bone powder.
2. The natural cultivation method of river crabs according to claim 1, which is characterized in that: the traditional Chinese medicine mixed powder I is prepared from the following raw materials in parts by weight: 1.5 parts of aloe powder, 2.5 parts of ginkgo, 0.3 part of pigeon manure, 1.5 parts of gardenia and 0.2 part of pomegranate bark.
3. The natural cultivation method of river crabs according to claim 2, wherein: the traditional Chinese medicine mixed powder II is prepared from the following raw materials in parts by weight: 1.5 parts of garlic, 1.5 parts of gardenia, 0.2 parts of fructus ulmi, 0.3 parts of bitter bamboo leaf and 0.2 parts of apocynum venetum leaf.
4. The natural cultivation method of river crabs as claimed in claim 3, wherein: in the step 4), the concentration of potassium permanganate is 2-5%.
5. The natural cultivation method of river crabs according to claim 4, wherein the natural cultivation method comprises the following steps: in the step 4), 1000-1200 crab seedlings are put per mu.
6. The natural cultivation method of river crabs according to claim 4, wherein the natural cultivation method comprises the following steps: the traditional Chinese medicine additive I is prepared from the following raw materials in parts by weight: 0.1 to 0.3 portion of liquorice, 0.2 to 0.4 portion of selfheal, 0.2 to 0.4 portion of lightyellow sophora root, 0.05 to 0.07 portion of Chinese taxillus twig, 0.02 to 0.04 portion of Chinese date, 0.02 to 0.04 portion of Chinese angelica and 0.01 to 0.03 portion of Chinese lobelia.
7. The natural cultivation method of river crabs according to claim 6, wherein: the traditional Chinese medicine additive II is prepared from the following raw materials in parts by weight: 0.2 to 0.3 portion of bupleurum, 0.02 to 0.04 portion of acanthopanax bark, 0.03 to 0.06 portion of motherwort, 0.1 to 0.4 portion of wild chrysanthemum, 0.2 to 0.4 portion of dandelion and 0.1 to 0.2 portion of mint.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610642486.8A CN106259071A (en) | 2016-08-08 | 2016-08-08 | A kind of natural cultural method of crab |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610642486.8A CN106259071A (en) | 2016-08-08 | 2016-08-08 | A kind of natural cultural method of crab |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106259071A true CN106259071A (en) | 2017-01-04 |
Family
ID=57666502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610642486.8A Pending CN106259071A (en) | 2016-08-08 | 2016-08-08 | A kind of natural cultural method of crab |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106259071A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106804499A (en) * | 2017-02-09 | 2017-06-09 | 合肥隆扬农业科技有限公司 | A kind of cultural method of river crab |
CN106888998A (en) * | 2017-02-28 | 2017-06-27 | 铜仁市凯盛水产养殖有限公司 | A kind of disease prevention method of steamed crab |
CN106889000A (en) * | 2017-02-28 | 2017-06-27 | 铜仁市凯盛水产养殖有限公司 | A kind of cultural method of steamed crab |
CN107361000A (en) * | 2017-08-24 | 2017-11-21 | 安徽江鲜渔业有限公司 | A kind of crab cultural method |
CN107926773A (en) * | 2017-11-30 | 2018-04-20 | 明光市裕阳新材料有限公司 | A kind of cultural method of loach |
CN108184738A (en) * | 2018-03-14 | 2018-06-22 | 和县明信水产养殖专业合作社 | A kind of river crab high-efficiency stepped formula pond breeding method |
CN109644915A (en) * | 2019-01-29 | 2019-04-19 | 钦州学院 | The method for improving Eriocheir hepuensis breeding survival rate by control temperature and taking the photograph bait rate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102715106A (en) * | 2012-05-21 | 2012-10-10 | 高雷 | Method for cultivating shrimp seed of macrobrachium rosenbergii |
CN103314902A (en) * | 2013-06-17 | 2013-09-25 | 苏州市阳澄湖现代农业发展有限公司 | Efficient breeding method for river crabs in pollution-free pond |
CN105248331A (en) * | 2015-10-31 | 2016-01-20 | 佛山市高明区杨和镇金峰水产养殖场 | Efficient cultivation method for giant freshwater prawns |
-
2016
- 2016-08-08 CN CN201610642486.8A patent/CN106259071A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102715106A (en) * | 2012-05-21 | 2012-10-10 | 高雷 | Method for cultivating shrimp seed of macrobrachium rosenbergii |
CN103314902A (en) * | 2013-06-17 | 2013-09-25 | 苏州市阳澄湖现代农业发展有限公司 | Efficient breeding method for river crabs in pollution-free pond |
CN105248331A (en) * | 2015-10-31 | 2016-01-20 | 佛山市高明区杨和镇金峰水产养殖场 | Efficient cultivation method for giant freshwater prawns |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106804499A (en) * | 2017-02-09 | 2017-06-09 | 合肥隆扬农业科技有限公司 | A kind of cultural method of river crab |
CN106888998A (en) * | 2017-02-28 | 2017-06-27 | 铜仁市凯盛水产养殖有限公司 | A kind of disease prevention method of steamed crab |
CN106889000A (en) * | 2017-02-28 | 2017-06-27 | 铜仁市凯盛水产养殖有限公司 | A kind of cultural method of steamed crab |
CN107361000A (en) * | 2017-08-24 | 2017-11-21 | 安徽江鲜渔业有限公司 | A kind of crab cultural method |
CN107926773A (en) * | 2017-11-30 | 2018-04-20 | 明光市裕阳新材料有限公司 | A kind of cultural method of loach |
CN108184738A (en) * | 2018-03-14 | 2018-06-22 | 和县明信水产养殖专业合作社 | A kind of river crab high-efficiency stepped formula pond breeding method |
CN109644915A (en) * | 2019-01-29 | 2019-04-19 | 钦州学院 | The method for improving Eriocheir hepuensis breeding survival rate by control temperature and taking the photograph bait rate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106259071A (en) | A kind of natural cultural method of crab | |
CN106212338A (en) | A kind of environment-protecting cultivation method of astacus | |
CN104855738A (en) | Compound feed for pig and preparation method of compound feed | |
CN104068279B (en) | A kind of eel feed containing Chinese medicine additive and preparation method thereof | |
CN106489836A (en) | A kind of pig cultivation method of preventing and treating parasite | |
CN103652501A (en) | Feed for treating cow mastitis and preparation method thereof | |
CN103652360B (en) | Feed for curing pig paratyphus and preparation method thereof | |
CN101933970B (en) | Plant medicament for treating venomous snake bite | |
CN104206916A (en) | Functional feed for treating ichthyoxeniosis of carps and preparation method of functional feed | |
CN107998313A (en) | A kind of Chinese medicine ferment for treating goat and preparation method thereof | |
CN106109793A (en) | A kind of Chinese medicine preparation treating pig endoparasite and preparation method thereof | |
CN104256166A (en) | Functional feed for treating bovine bluetongue and preparation method thereof | |
CN104543576B (en) | Prevent and treat composite vegetables extractive feed addictive and its preparation method application of grice diarrhoea | |
CN105851592A (en) | Sow mastitis feed additive with slow-release effect and preparation method | |
CN104969906B (en) | A kind of testudinate hatching material and preparation method thereof | |
CN105106725A (en) | Swordtail bacillary enteritis preventing feed additive and preparation method thereof | |
KR20110091959A (en) | Anhydrous lactobacillus fermentation health function food composition with cancer curing improvements and its preparation method | |
CN104970223A (en) | Compound feed for cattle and preparation method of compound feed | |
KR20160147424A (en) | An enzyme composition for treating metabolic disorders including extracts wasong | |
CN106259076A (en) | A kind of cultural method of crab | |
CN105028315B (en) | A kind of testudinate hatching material and preparation method thereof | |
CN106259077A (en) | A kind of ecological cultivation method of astacus | |
CN106259079A (en) | A kind of ecological cultivation method of crab | |
KR101969983B1 (en) | Shampoo composition for improving hair loss containing soil-board salt and method the same | |
CN105341534A (en) | Feed additive for preventing white-spot disease of parrot fishes and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170104 |
|
WD01 | Invention patent application deemed withdrawn after publication |